Good news I think for those of us with gating mutations other than G551D.
http://www.youtube.com/watch?v=xguSP9-HbSw
http://www.youtube.com/watch?v=YkDUbvFpNsA
Basically, saying because most other gating mutations are so rare, it won't be possible to carry out clinical trials, and that the FDA will have to allow use of the drug on the basis of in vitro cell work i.e. data found in the lab to show VX770 works on other class III mutations.
Meaning that it will be a case of suck it and see! i.e. try it for a few weeks, if there are positive clinical changes, then continue...
http://www.youtube.com/watch?v=xguSP9-HbSw
http://www.youtube.com/watch?v=YkDUbvFpNsA
Basically, saying because most other gating mutations are so rare, it won't be possible to carry out clinical trials, and that the FDA will have to allow use of the drug on the basis of in vitro cell work i.e. data found in the lab to show VX770 works on other class III mutations.
Meaning that it will be a case of suck it and see! i.e. try it for a few weeks, if there are positive clinical changes, then continue...